Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldblatt

Showing results (21-30 of 242) with videos related to

Pageof 25
Sort By:
Annals of Internal Medicine|December 21, 2006
John Loesch and Harry Goldblatt: two great pioneers in circulation researchDavid Goldblatt, Peter J Goldblatt
The Lancet. Infectious Diseases|June 29, 2019
Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccines - Authors' replyDavid Goldblatt, Shabir A Madhi
The Lancet. Infectious Diseases|April 13, 2019
The duopoly of ten-valent and 13-valent pneumococcal conjugate vaccines: do they differ?Shabir A Madhi, David Goldblatt
Vaccine|August 13, 2013
Using the impact of pneumococcal vaccines on nasopharyngeal carriage to aid licensing and vaccine implementation; a PneumoCarr meeting report March 27-28, 2012, GenevaDavid Goldblatt, Meena Ramakrishnan, Katherine O'Brien
The Journal of Infectious Diseases|January 25, 2002
Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adultsDavid Goldblatt, Ray Borrow, Elizabeth Miller
Expert Review of Vaccines|March 22, 2016
Maternal and neonatal pneumococcal vaccination - where are we now?Ed Clarke, Beate Kampmann, David Goldblatt
Advances in Experimental Medicine and Biology|August 19, 2005
Chronic granulomatous disease: from genetic defect to clinical presentationJohan Bylund, David Goldblatt, David P Speert
The Lancet. Infectious Diseases|August 24, 2007
Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?Katherine L O'Brien, Michael Hochman, David Goldblatt
Clinical and Vaccine Immunology : CVI|March 9, 2006
Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric seraIsabelle Henckaerts, David Goldblatt, Lindsey Ashton, et al.
The Pediatric Infectious Disease Journal|December 17, 2013
Why do we need a systematic review of pneumococcal conjugate vaccine dosing schedules?Katherine L O'Brien, David Goldblatt, Cynthia G Whitney
Pageof 25

Showing results (21-30 of 242) with videos related to

Sort By:
Pageof 25
Annals of Internal Medicine|December 21, 2006
John Loesch and Harry Goldblatt: two great pioneers in circulation researchDavid Goldblatt, Peter J Goldblatt
The Lancet. Infectious Diseases|June 29, 2019
Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccines - Authors' replyDavid Goldblatt, Shabir A Madhi
The Lancet. Infectious Diseases|April 13, 2019
The duopoly of ten-valent and 13-valent pneumococcal conjugate vaccines: do they differ?Shabir A Madhi, David Goldblatt
Vaccine|August 13, 2013
Using the impact of pneumococcal vaccines on nasopharyngeal carriage to aid licensing and vaccine implementation; a PneumoCarr meeting report March 27-28, 2012, GenevaDavid Goldblatt, Meena Ramakrishnan, Katherine O'Brien
The Journal of Infectious Diseases|January 25, 2002
Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adultsDavid Goldblatt, Ray Borrow, Elizabeth Miller
Expert Review of Vaccines|March 22, 2016
Maternal and neonatal pneumococcal vaccination - where are we now?Ed Clarke, Beate Kampmann, David Goldblatt
Advances in Experimental Medicine and Biology|August 19, 2005
Chronic granulomatous disease: from genetic defect to clinical presentationJohan Bylund, David Goldblatt, David P Speert
The Lancet. Infectious Diseases|August 24, 2007
Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?Katherine L O'Brien, Michael Hochman, David Goldblatt
Clinical and Vaccine Immunology : CVI|March 9, 2006
Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric seraIsabelle Henckaerts, David Goldblatt, Lindsey Ashton, et al.
The Pediatric Infectious Disease Journal|December 17, 2013
Why do we need a systematic review of pneumococcal conjugate vaccine dosing schedules?Katherine L O'Brien, David Goldblatt, Cynthia G Whitney
Pageof 25